Approvals/CIMA-AEMPS/RANOLAZINA PENSA 375 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG

Approved

STANDARD

RANOLAZINA PENSA 375 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG

Towa Pharmaceutical S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: aae92d9ffbcb8ea9
Drug Cima Aemps Name: RANOLAZINA PENSA 375 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA EFG
Register Number: 89167
Holder Company Name: Towa Pharmaceutical S.A.
Marketing Company Name: Towa Pharmaceutical S.A.
Authorization Date: 2024-02-06
Dosage Form: COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose: 375 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Towa Pharmaceutical S.A.

RANOLAZINA

375 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Feb 6, 2024

Approval ID

aae92d9ffbcb8ea9

Type

Standard